EGFR and breast cancer: On the other hand, resistance to drugs against EGFR has been a major clinical problem.42 We demonstrated that mouse tail vein injection of agomiR-338-3p, a modified miR-338-3p mimics, significantly decreased the incidence of breast cancer metastasis to the lung.